26 February 2024
GSK announces positive headline results from EAGLE-1 phase III trial for gepotidacin in uncomplicated urogenital gonorrhoea (GC) · EAGLE-1 trial met its primary efficacy endpoint…
23 February 2024
BHP | Financial results for the half year ended 31 December 2023 20 February 2024 Financial results for the half year ended 31 December…
22 February 2024
22 February 2024 Acquisition of Gracell completed AstraZeneca today announced the successful completion of the acquisition of Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage…
22 February 2024 07:00 GMT AstraZeneca prices a $5bn bond offering AstraZeneca PLC (“AstraZeneca”) announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced a four…
Herald Investment Trust plc Annual Financial Report For the year ended 31 December 2023 Results and dividend The net asset value (‘NAV’) of the…
Underlying operating profit of £1.6bn and underlying margin of 10.3%, reflecting the impact of our strategic initiatives, with commercial optimisation and cost efficiency benefits…
22 February 2024 LLOYDS BANKING GROUP PLC – ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2023 In accordance with Listing Rule…
21 February 2024
Nestlé reports full-year results for 2023 FEB 22, 2024 Back to Press releases Vevey, Switzerland [Ad hoc announcement pursuant to Art. 53 LR] Follow…